Cravath represented the underwriters in connection with the $3 billion registered senior notes offering of Cencora, Inc., a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. Proceeds of the offering were used to repay, in full, the term loan facility used to finance Cencora, Inc's acquisition of OneOncology. The transaction closed on February 13, 2026.

The Cravath team included partner Ryan J. Patrone and associates Courtney T. Seager and R. Christian Dunn on capital markets matters, and partner Arvind Ravichandran and associate Ruth Goldstein Schapiro on tax matters. Han Wen Zhang also worked on capital markets matters and Andrew Stone worked on tax matters.